Search All UT System Experts

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells

Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson, Paul I. Pisacane, Mark X. Sliwkowski, James T. Forbes, Carlos L. Arteaga

Research output: Contribution to journal › Article › peer-review

341 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences